Current antioxidant molecular therapies for oxidative stress-related ailments

Current Gene Therapy

Volumn 8, Issue 4, 2008, Pages 256-263

  Ramos Márquez, Martha E ^a   Siller López, Fernando ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Antioxidants; Catalase; Gene therapy; Gene transfer techniques; Glutathione; Heme oxygenase; Oxidative stress; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; COMPLEMENTARY DNA; CYTIDINE DEAMINASE; DIHYDROFOLATE REDUCTASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE A3; HEME OXYGENASE 1; LIPOSOME; MANGANESE SUPEROXIDE DISMUTASE; PEROXIREDOXIN; PEROXIREDOXIN 3; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; RECOMBINANT HEME OXYGENASE 1; RECOMBINANT PROTEIN; RECOMBINANT SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE; THIOREDOXIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTHRITIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL REGENERATION; CELL SPECIFICITY; CELL TRANSPLANTATION; CELLULAR STRESS RESPONSE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG MECHANISM; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC RECOMBINATION; GRAFT REJECTION; HEART PROTECTION; HOMEOSTASIS; HUMAN; HYPERTENSION; ISCHEMIA; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; LUNG INJURY; MOLECULAR THERAPY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OPTIC NEURITIS; OXIDATIVE STRESS; PANCREAS CANCER; PEYRONIE DISEASE; RADIATION INJURY; REPERFUSION INJURY; REVIEW; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; HUMANS; LUNG DISEASES; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 53249090596     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652308785160665     Document Type: Review

References (103)

1. Holtzman JL. Minireview: role of reactive oxygen and metabolite binding in drug toxicity. Life Sci 1982; 30(1): 1-9.
2. Halliwell B, Gutteridge JM. The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med 1985; 8(2): 89-193.
3. Brent JA, Rumack BH. Role of free radicals in toxic hepatic injury. I. Free radical biochemistry. J Toxicol Clin Toxicol 1993; 31(1): 139-71.
4. Halliwell B. Antioxidants in human health and disease, Annu Rev Nutr 1996; 16: 33-50.
5. Chaudiere J, Ferrari-Iliou R. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 1999; 37(9-10): 949-62.
6. Krinsky NI. Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 1992; 200(2): 248-54.
7. Valko, M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160(1): 1-40.
8. Behl C, Moosmann B. Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic Biol Med 2002; 33(2): 182-91. 9 Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002; 32(9): 797-803.
9. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 2000; 28(9):1405-20.
10. Jaeschke H. Mechanisms of oxidant stress-induced acute tissue injury. Proc Soc Exp Biol Med 1995; 209(2): 104-11.
11. Peng J, Jones GL, Watson K. Stress proteins as biomarkers of oxidative stress: effects of antioxidant supplements. Free Radic Biol Med 2000; 28(11):1598-606.
12. Lewis GR. Should doctors discourage nutritional supplementation? A cardiovascular perspective. Heart Lung Circ 2004; 13(3): 245-51.
13. Sumien N, Forster MJ, Sohal RS. Supplementation with vitamin E fads to attenuate oxidative damage in aged mice. Exp Gerontol 2003; 38(6): 699-704.
14. Winter K, Pagoria D, Geurtsen W. The effect of antioxidants on oxidative DNA damage induced by visible-light-irradiated camphorquinone/N, N-dimethyl-p-toluidine. Biomaterials 2005; 26(26): 5321-9.
15. Adlam VJ, Harrison JC, Porteous CM, et al. Targeung an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 2005; 19(9): 1088-95.
16. Thomas PD, Campbell MJ, Kejariwal A, et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 2003; 13(9):2129-41.
17. Mi H, Guo N, Kejariwal A, Thomas PD. PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res 2007; 35(Database issue): D247-52.
18. Gene_therapy. Merriam-Webster Online Dictionary. 2008 updated 2008; cited 2008 July 7]; Available from: http://www.merriam-webster.com/ dictionary/gene therapy.
19. Kussmaul L, Hirst J. The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc Natl Acad Sci U S A 2006; 103(20): 7607-12.
20. Grisham MB, Ware K, Marshall S, Yamada T, Sandhu IS. Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects. Dig Dis Sci 1992; 37(9): 1383-9.
21. Flint DH, Tuminello JF, Emptage MH. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem 1993; 268(30): 22369-76.
22. Schomburg D. BRENDA. The Comprehensive Enzyme Information System 2008 [updated 2008; cited; Available from: http://www.brenda-enzymes.info/.
23. Epperly MW, Tyurina YY, Nie S, et al. MnSOD-plasmid liposome gene therapy decreases ionizing irradiation-induced lipid peroxidation of the esophagus. In Vivo 2005; 19(6): 997-1004.
24. Greenberger JS, Epperly MW, Gretton J, et al. Radioprotective gene therapy. Curr Gene Ther 2003; 3(3): 183-95.
25. Guo H, Epperly MW, Bernarding M, et al. Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) intratracheal gene therapy reduction of irradiation-induced inflammatory cytokines does not protect orthotopic Lewis lung carcinomas. In Vivo 2003; 17(1): 13-21.
26. Kanai AJ, Zeidel ML, Lavelle JP, et al. Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis. Am J Physiol Renal Physiol 2002; 283(6): F1304-12.
27. Epperly MW, Sikora CA, DeFilippi SJ, et al. Pulmonary irradiation-induced expression of VCAM-I and ICAM-I is decreased by manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) gene therapy. Biol Blood Marrow Transplant 2002; 8(4): 175-87.
28. Epperly MW, Gretton JA, DeFilippi SJ, et al. Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutaseplasmid/liposome (SOD2-PL) gene therapy. Radiat Res 2001; 155(1 Pt 1): 2-14.
29. Guo HL, Wolfe D, Epperly MW, et al. Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. J Gastrointest Surg 2003; 7(2): 229-35; discussion 35-6.
30. Southgate TD, Sheard V, Milsom MD, et al. Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase. J Gene Med 2006; 8(5): 557-65.
31. NIH OBA. Genetic Modification Clinical Research Information System. NIH Office of Biotechnology Activities; 2008 [updated 2008; cited 2008 June 12]; Available from: http://www.gemcris.od.nih.gov/.
32. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 2004; 95(2): 210-6.
33. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109(19): 2357-62.
34. Chu Y, Iida S, Lund DD, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 2003; 92(4): 461-8.
35. Fennell JP, Brosnan MJ, Frater AJ, et al. Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther 2002; 9(2): 110-7.
36. Li L, Crockett E, Wang DH, Galligan JJ, Fink GD, Chen AF. Gene transfer of endothelial NO synthase and manganese superoxide dismutase on arterial vascular cell adhesion molecule-1 expression and superoxide production in deoxycorticosterone acetate-salt hypertension. Arterioscler Thromb Vasc Biol 2002; 22(2): 249-55.
37. Laukkanen MO, Kivela A, Rissanen T, et al. Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta. Circulation 2002; 106(15): 1999-2003.
38. Li Q, Bolli R, Qiu Y, Tang XL, Murphree SS, French BA. Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation 1998; 98(14): 1438-48.
39. Qian Z, Haessler M, Lemos JA, et al. Targeting vascular injury using Hantavirus-pseudotyped lentiviral vectors. Mol Ther 2006; 13(4): 694-704.
40. Agrawal RS, Muangman S, Layne MD, et al. Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival. Gene Ther 2004; 11(12): 962-9.
41. Abunasra HJ, Smolenski RT, Yap J, Sheppard M, O'Brien T, Yacoub MH. Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation. J Thorac Cardiovasc Surg 2003; 125(5): 998-1006.
42. Yang J, Marden JJ, Fan C, et al. Genetic redox preconditioning differentially modulates AP-1 and NF kappa B responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis. Mol Ther 2003; 7(3): 341-53.
43. Danel C, Erzurum SC, Prayssac P, et al. Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum Gene Ther 1998; 9(10): 1487-96.
44. Abunasra H, Smolenski RT, Yap J, Jayakumar J, Sheppard M, Yacoub MH. Comparison of two gene transfer models for the attenuation of myocardial ischemia-reperfusion injury following preservation for cardiac transplantation. Eur J Cardiothorac Surg 2006; 29(5): 772-8.
45. Turunen P, Puhakka HL, Heikura T, et al. Extracellular superoxide dismutase with vaccinia virus anti-inflammatory protein 35K or tissue inhibitor of metalloproteinase-1: Combination gene therapy in the treatment of vein graft stenosis in rabbits. Hum Gene Ther 2006; 17(4): 405-14.
46. Riedl CR, Sternig P, Galle G, et al. Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study. Eur Urol 2005; 48(4): 656-61.
47. Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J. SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I. Ann Neurol 2004; 56(2): 182-91.
48. Barkats M, Horellou P, Colin P, Millecamps S, Faucon-Biguet N, Mallet J. 1-methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase. J Neurosci Res 2006; 83(2): 233-42.
49. Kawamoto K, Sha SH, Minoda R, et al. Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther 2004; 9(2): 173-81.
50. Dai L, Claxson A, Marklund SL, et al. Amelioration of antigen-induced arthritis in rats by transfer of extracellular superoxide dismutase and catalase genes. Gene Ther 2003; 10(7): 550-8.
51. Iyama S, Okamoto T, Sato T, et al. Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum 2001; 44(9): 2160-7.
52. Watanabe Y, Chu Y, Andresen JJ, Nakane H, Faraci FM, Heistad DD. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 2003; 34(2): 434-40.
53. Darby Weydert CJ, Smith BB, Xu L, et al. Inhibition of oral cancer cell growth by adenovirusMnSOD plus BCNU treatment. Free Radic Biol Med 2003; 34(3): 316-29.
54. Tanaka M, Kogawa K, Nakamura K, et al. Anti-metastatic gene therapy utilizing subcutaneous inoculation of EC-SOD gene transduced autologous fibroblast suppressed lung metastasis of Meth-A cells and 3LL cells in mice. Gene Ther 2001; 8(2): 149-56.
55. Zhang Y, Gu J, Zhao L, et al. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy. Cancer Res 2006; 66(8): 4291-8.
56. Zhong Z, Froh M, Wheeler MD, Smutney O, Lehmann TG, Thurman RG. Viral gene delivery of superoxide dismutase attenuates experimental cholestasis-induced liver fibrosis in the rat. Gene Ther 2002; 9(3): 183-91.
57. Laukkanen MO, Leppanen P, Turunen P, Tuomisto T, Naarala J, Yla-Herttuala S. EC-SOD gene therapy reduces paracetamol-induced liver damage in mice. J Gene Med 2001; 3(4): 321-5.
58. Wheeler MD, Kono H, Yin M, et al. Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats. Gastroenterology 2001; 120(5): 1241-50.
59. Okumura K, Nishiguchi K, Tanigawara. Y, Mori S, Iwakawa S, Komada F. Enhanced anti-inflammatory effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts in vitro and in vivo. Pharm Res 1997; 14(9): 1223-7.
60. Bivalacqua TJ, Usta MF, Kendirci M, et al. Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med 2005, 2(2): 187-97; discussion 97-8.
61. Ghersa P, Gobert RP, Sattonnet-Roche P, Richards CA, Merlo Pich E, Hooft van Huijsduijnen R. Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Gene Ther 1998; 5(9): 1213-26.
62. Kinoshita A, Kobayashi D, Saitoh Y, et al. Regulation of exogenous gene expression by superoxide. Pharm Res 2006, 23(11), 2536-41.
63. Phillips MI, Tang Y, Schmidt-Ott K, Qian K, Kagiyama S. Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection. Hypertension 2002; 39(2 Pt 2): 651-5.
64. Dulak J, Zagorska, A, Wegiel B, Loboda A, Jozkowicz A. New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genes. Cell Biochem Biophys 2006 44(1): 31-42.
65. Kirkby KA, Adin CA. Products of heme oxygenase and their potential therapeutic applications, Am J Physiol Renal Physiol 2006; 290(3): F563-71.
66. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86(2): 583-650
67. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: encyclopedia for genes, proteins and diseases. Weizmann Institute of Science, Bioinformatics Unit and Genome Center (Rehovot, Israel) 1997: http://www.genecards.org/. Date of access: 03/1/2007.
68. Dulak J, Jozkowicz A. Carbon monoxide - a "new" gaseous modulator of gene expression. Acta Biochim Pol 2003; 50(1): 31-47.
69. Weng YH, Tatarov A, Bartos BP, Contag CK Dennery PA. HO-1 expression in type II pneumocytes after transpulmonary gene delivery. Am J Physiol Lung Cell Mol Physiol 2000; 278(6): L1273-9.
70. Was H, Cichon T, Smolarczyk R, et al. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 2006; 169(6): 2181-98.
71. Dennery PA. Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 2000; 36: 181-99.
72. Dennery PA, Visner G, Weng YH, et al. Resistance to hyperoxia with heme oxygenase-1 disruption: role of iron. Free Radic Biol Med 2003, 34(1): 124-33.
73. Pachori AS, Melo LG, Zhang L, Solomon SD, Dzau VJ. Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery. J Am Coll Cardiol 2006; 47(3): 635-43.
74. Liu J, Du J, Zhang Y, et al. Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase. Hum Gene Ther 2006; 17(1): 105-16.
75. Tang YL, Qian K, Zhang YC, Shen L, Phillips MI. A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J Cardiovasc Pharmacol Ther 2005; 10(4): 251-63.
76. Melo LG, Agrawal R, Zhang L, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus. mediated delivery heme oxygenase gene. Circulation 2002; 105(5): 602-7.
77. Chauveau C, Bouchet D, Roussel JC, et al. Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2002; 2(7): 581-92.
78. Tsui TY, Wu, X, Lau CK, et al. Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 2003; 107(20): 2623-9.
79. Braudeau C, Bouchet D, Tesson L, et al. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 2004; 11(8): 701-10.
80. Tsui TY, Lau CK, Ma J, et al. Adeno-associated virus-mediated heme oxygenase-1 gene transfer suppresses the progiression of micronodular cirrhosis in rats. World J Gastroenterol 2006; 12(13): 2016-23.
81. McCarter SD, Badhwar A, Scott JR, et al. Remote liver injury is attenuated by adenovirus-mediated gene transfer of heme oxygenase-1 during the systemic inflammatory response syndrome. Microcirculation 2004; 11(7): 587-95.
82. Sass G, Soares MC, Yamashita Y, et al. Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology 2003; 38(4): 909-18.
83. Coito AJ, Buelow R, Shen XD, et al. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 2002; 74(1): 96-102.
84. Hammond CL, Lee TK, Ballatori N. Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol 2001; 34(6): 946-54.
85. Anderson ME. Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 1998; 111-112: 1-14.
86. Chang P, Cheng E, Brooke S, Sapolsky, R. Marked differences in the efficacy of post-insult gene therapy with catalase versus glutathione peroxidase. Brain Res 2005, 1063(1): 27-31.
87. Hoehn B, Yenari MA, Sapolsky RM, Steinberg GK. Glutathione peroxidase overexpression inhibits cytochrome C release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 2003; 34(10): 2489-94.
88. Ridet JL, Bensadoun JC, Deglon N, Aebischer P, Zurn AD. Lenti-virus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease. Neurobiol Dis 2006; 21(1): 29-34.
89. Liu J, Hinkhouse MM, Sun W, et al. Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype. Hum Gene Ther 2004; 15(3): 239-50.
90. Mirault ME, Tremblay A, Beaudoin N, Tremblay M. Overexpression of seleno-glutathione peroxidase by gene transfer enhances the resistance of T47D human breast cells to clastogenic oxidants. J Biol Chem 1991; 266(31): 20752-60.
91. Fernandes CJ, Rong L, Tarmint T, et al. Stable transfection of Chinese hamster ovary cells with glutamate-cysteine ligase catalytic subunit cDNA confers increased resistance to tert-butyl hydroperoxide toxicity, Toxicol Lett 2002; 136(2): 107-20.
92. Rappa G, Gamcsik MP, Mitina RL, Baum C, Fodstad O, Lorico, A. Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy. Eur J Cancer 2003 39(1): 120-8.
93. O'Donovan DJ, Katkin JP, Tamura T, et al. Gene transfer of mitochondrially targeted glutathione reductase protects H441 cells from t-butyl hydroperoxide-induced oxidant stresses. Am J Respir Cell Mol Biol 1999; 20(2): 256-63.
94. Belzile JP, Karatzas A, Shiu HY, Letourneau S, Palerme JS, Cournoyer D. Increased resistance to nitrogen mustards and antifolates following in vitro selection of marine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase. Cancer Gene Ther 2003; 10(8): 637-46.
95. Letourneau S, Palerme JS, Delisle JS, Beausejour CM, Momparler RL, Cournoyer D. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts. Cancer Gene Ther 2000, 7(5): 757-65.
96. Kuga T, Sakamaki S, Matsunaga T, et al. Fibronectin fragment-facilitated retroviral transfer of the glutathione-S-transferase pi gene into CD34+ cells to protect them against alkylating agents. Hum Gene Ther 1997, 8(16), 1901-10.
97. Letourneau S, Greenbaum M, Cournoyer D. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells. Hum Gene Ther 1996; 7(7): 831-40.
98. Rex TS, Tsui I, Hahn P, et al. Adenovirus-mediated delivery of catalase to retinal pigment epithelial cells protects neighboring photoreceptors from photo-oxidative stress. Hum Gene Ther 2004; 15(10): 960-7.
99. Zhu HL, Stewart AS, Taylor MD, Vijayasarathy C, Gardner TJ, Sweeney HL. Blocking free radical production via adenoviral gene transfer decreases cardiac ischemia-reperfusion injury. Mol Ther 2000; 2(5): 470-5.
100. Guy J, Qi X, Wang H, Hauswirth WW. Adenoviral gene therapy with catalase suppresses experimental optic neuritis. Arch Ophthalmol 1999; 117(11): 1533-9.
101. Hattori F, Murayama N, Noshita T, Oikawa S. Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J Neurochem 2003; 86(4): 860-8.
102. Wang Y, Manevich Y, Feinstein SI, Fisher AB. Adenovirus-mediated transfer of the 1-cys peroxiredoxin gene to mouse lung protects against hyperoxic injury. Am J Physiol Lung Cell Mol Physiol 2004, 286(6): L1188-93.
103. Tsutsui T, Koide H, Fukahori H, et al. Adenoviral transfection of hepatocytes with the thioredoxin gene confers protection against apoptosis and necrosis. Biochem Biophys Res Commun 2003; 307(4): 765-70.